New blood test could help develop smart cancer drug
A new blood test that detects changes in the levels of metabolites in the blood can help identify if a new smart cancer drug is doing its job or not, a new study has revealed. Researchers from The Institute of Cancer Research (ICR) in London postulated that cancer drugs affect the amount of metabolites present in the blood of patients which could be used as a gauge whether the drug is effective in targeting cancer cells. Metabolites serve as the segments that make up proteins and fats. For their study, the researchers analyzed 180 blood markers. They found that the assortment of the metabolites provides an accurate assessment of the vulnerability of the cancer cells in 41 patients diagnosed with advanced cancers and who were given pictilisib.
Read more:
B●●t J●●●d and 3 others like this